Press release
Chronic Myeloid Leukemia (CML) Treatment Market Size, Share, Growth ,Analysis 2024-2033
Chronic Myeloid Leukemia (CML) Treatment
As per the report, the chronic myeloid leukemia (cml) treatment market size has grown strongly in recent years. It will grow from $7.73 billion in 2023 to $8.18 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The chronic myeloid leukemia (cml) treatment market size is expected to see strong growth in the next few years. It will grow to $10.4 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12084&type=smp
Rising Incidence Of Chronic Myeloid Leukemia (CML)
The rising incidence and prevalence of chronic myeloid leukemia (CML) population is expected to propel the growth of the chronic myeloid leukemia (CML) treatment market going forward. Chronic myeloid leukemia also known as chronic myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the overproduction of immature white blood cells called myeloid cells. Chronic myeloid leukemia (CML) treatment helps to slow the progression of cancer and stop it from reaching an advanced phase. For instance, in March 2023, according to the American Society of Clinical Oncology, a US-based professional organization representing physicians of all oncology sub-specialties, in the United States, in 2023, around 35,730 persons (19,860 men and 15,870 women) are anticipated to receive a multiple myeloma diagnosis and 12,590 deaths from this illness are anticipated in 2023 (7,000 males and 5,590 women). Therefore, the rising incidence and prevalence of chronic myeloid leukemia (CML) population is driving the growth of the chronic myeloid leukemia (CML) treatment market going forward.
Innovation In Drug Development For Better Treatment
Product Innovation is a key trend gaining popularity in the chronic myeloid leukemia (CML) treatment market. Companies operating in the chronic myeloid leukemia (CML) treatment market are adopting new technologies to sustain their position in the market. For instance, in October 2021, Novartis, a Switzerland-based multinational pharmaceutical corporation, announced FDA (Foods and Drugs Association) approval of Scemblix (asciminib) for the treatment of chronic myeloid leukemia. Scemblix is the first FDA-approved CML treatment. Scemblix works by binding to the ABL myristoyl pocket and is used to treat patients who experience resistance and, or intolerance to currently available TKI therapies1-3. At 24 weeks, Scemblix outperformed Bosulif (bosutinib) in terms of major molecular response (MMR) rate (25% vs. 13%) and more than three times lower discontinuation rates due to adverse effects (7% vs. 25%).
The chronic myeloid leukemia (cml) treatment market covered in this report is segmented -
1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant
2) By Drug Type: Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types
3) By Application: Hospitals, Clinic, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12084&type=discount
Major companies operating in the chronic myeloid leukemia (cml) treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Hospira Inc., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Stragen Pharma SA, Orca Bio, Bio-Path Holdings Inc.
Contents of the report:
1. Executive Summary
2. Chronic Myeloid Leukemia (CML) Treatment Market Report Structure
3. Chronic Myeloid Leukemia (CML) Treatment Market Trends And Strategies
4. Chronic Myeloid Leukemia (CML) Treatment Market - Macro Economic Scenario
5. Chronic Myeloid Leukemia (CML) Treatment Market Size And Growth
…..
27. Chronic Myeloid Leukemia (CML) Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-cml-treatment-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Myeloid Leukemia (CML) Treatment Market Size, Share, Growth ,Analysis 2024-2033 here
News-ID: 3590512 • Views: …
More Releases from The Business research company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for CML
Chronic Myelocytic Leukemia (CML) Market New Product Development & Latest Trends
Introduction
Chronic myelocytic leukemia (CML), also known as chronic myeloid leukemia, is a rare type of blood cancer characterized by the uncontrolled growth of abnormal white blood cells. It is strongly associated with the Philadelphia chromosome and the BCR-ABL fusion gene, which leads to continuous activation of tyrosine kinase signaling.
Over the past two decades, the approval of tyrosine kinase inhibitors (TKIs) revolutionized CML management, transforming it from a once-fatal condition into…
Chronic Myeloid Leukemia (CML) Market Set to Witness Significant Growth by 2025- …
Introduction
Chronic myeloid leukemia (CML), a rare blood cancer caused by the BCR-ABL gene fusion, has undergone a therapeutic revolution over the last two decades. Once associated with poor survival rates, CML is now considered a largely manageable chronic condition, thanks to tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, nilotinib, and ponatinib. These targeted therapies directly inhibit the abnormal kinase activity driving uncontrolled white blood cell proliferation, dramatically improving long-term…
Chronic Myeloid Leukemia (CML) Treatment Market Analysis and Projections 2024
"The Business Research Company recently released a comprehensive report on the Global Chronic Myeloid Leukemia (CML) Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Chronic Myeloid Leukemia (CML) Treatment Market Size, Share, Growth Analysis, Fo …
The Business Research Company's Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2023 identifies the rising incidence and prevalence of chronic myeloid leukemia (CML) population is expected to propel the growth of the chronic myeloid leukemia (CML) treatment market going forward. Chronic myeloid leukemia also known as chronic myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the overproduction of immature…
RF Signal Amplifier Market Growth Analysis 2023-2030| ADI, Analog Devices, CML M …
The RF Signal Amplifier market analysis will be helpful in understanding the end-user profile, the adoption rate of key segments among them, and other developmental patterns. The study looks more closely at the tactics and methods implemented by significant stakeholders and investors to accelerate the development of the product. In order to pinpoint the profitable market niches, the investigation focuses on the impending investment pockets across numerous areas.
From 2023 to…
Angle Rolls Market with top Tauring Group, Davi Promau, CML International S.p.A, …
"Angle Rolls Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/24570
UpMarketResearch offers a latest published report on “Global Angle Rolls Market Analysis and Forecast 2019 - 2026” delivering key insights and providing a competitive advantage to…
